Finzati - Logo
NVST logo

Envista Holdings Corp

NVST • Medical - Instruments & Supplies
$22.97
— 0.00 (0.00%)
Current price
EarningsLatest report: Jul 3, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$3.73B
Growth
-1.2%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.37Consistent free cash flow · 5/5Manageable debt level · 0.55Healthy liquidity · 2.38Expensive earnings multiple · 77.6
Financial data as of: Jul 3, 2026, 12:00 AM UTCLast earnings update: Jul 3, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:44 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$22.97
Change0.00%
Shares Out164.10M
Market Cap$3.73B
Enterprise Value$3.73B
52W Range18.77 - 30.42
Beta0.86
P/E39.23
P/S1.30
P/B1,211,426.39
P/FCF16.04
EV/Sales1.30

Investment DNA

How strong this company looks for long-term investors

59
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
86/100
Growth Potential
Revenue and expansion
25/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Positive free cash flow · 1.37Consistent free cash flow · 5/5Manageable debt level · 0.55Healthy liquidity · 2.38Expensive earnings multiple · 77.6Negative growth trend

Analyst view

Analyst sentiment and price target

NVST
Analyst sentiment
Based on 20 analyst votes · 2026-10-20
68/100
Neutral
Bullish
8
Hold
11
Bearish
1
Price Target
2026-08-07
Low
$23.00
Mean
$29.14
Median
$29.00
High
$34.00

Company Overview

IPO: 9/18/2019
Industry: Medical - Instruments & Supplies
P/B i: 1211426.39
Debt / Equity i: 0.55
Operating Margin: 8.30%
Net Margin: 1.73%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.55
Current Ratio: 2.38
Quick Ratio: 2.04
Status: Strong

Insider Transactions

Recent executive and insider activity

Keel Paul A
Transaction: 05/25/2026
SELL
Change
-12,811
Price
$23.43
Filing
05/27/2026
Type
SELL
Huennekens R Scott
Transaction: 05/19/2026
BUY
Change
+12,585
Price
Not reported
Filing
05/21/2026
Type
BUY
Raskas Daniel
Transaction: 05/19/2026
BUY
Change
+9,330
Price
Not reported
Filing
05/21/2026
Type
BUY